HLYK · XBRL financial data

HealthLynked financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal years (HLYK's year ends in late December)

In thousands of dollarsDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024†Dec 31, 2025
Revenue6,1339,1985,8585,7223,008—
Selling, general and administrative3,0634,9304,5773,6233,0392,036
Total operating expenses9,20514,24114,5189,8747,6864,179
Other operating income (expense)—(5,369)592———
Operating income (loss)(3,072)(5,043)(8,659)(4,152)(4,678)(2,113)
Interest expense——021——
Net income (loss)(5,755)(10,413)(8,816)(1,012)(6,131)(3,280)
Earnings per share, basic USD per share(0.04)(0.05)(0.04)0.00(0.02)(1.16)
Earnings per share, diluted USD per share(0.04)(0.05)(0.04)0.00(0.02)(1.16)
Weighted average shares, basic thousands of shares142,825227,847243,420262,892281,5442,836
Weighted average shares, diluted thousands of shares142,825227,847243,420262,892281,5442,836
  • † Share count changed about 1/96 in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Balance sheet

CSV

Fiscal years (HLYK's year ends in late December)

In thousands of dollarsDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024†Dec 31, 2025
Cash and cash equivalents1623,292622477637
Accounts receivable87867221——
Inventory951351931334518
Prepaid and other current assets5913893505733
Total current assets4043,6502,1456561,6411,552
Property and equipment, net43735041329117775
Right-of-use asset—52754093636176
Goodwill1,1481,148320———
Total assets8,02710,6954,5814,2802,2231,702
Accrued liabilities——3909190177
Current portion of long-term debt723450————
Total current liabilities4,8821,9183,4752,4124,6907,013
Long-term debt1813945———
Lease liability, non-current2742391986131541
Total liabilities6,6773,4914,2663,4755,3527,464
Accumulated deficit(21,785)(32,205)(41,021)(42,033)(48,165)(50,539)
Total stockholders' equity1,3507,204314805(3,129)(5,762)
Total liabilities and equity8,02710,6954,5814,2802,2231,702
Common shares outstanding (cover page) thousands of shares226,075238,033259,153281,065281,9482,941
  • † Share count changed about 1/96 in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Cash flows

CSV

Fiscal years (HLYK's year ends in late December)

In thousands of dollarsDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024†Dec 31, 2025
Net income (loss)(5,755)(10,413)(8,816)(1,012)(6,131)(3,280)
Stock-based compensation——100304210159
Depreciation and amortization—828829352283102
Net cash from operating activities(2,117)(3,770)(4,363)(4,145)(3,494)(1,714)
Purchases of property and equipment25192423—
Net cash from investing activities1,812(341)(545)3,506422125
Proceeds from issuing common stock1,1876,94995785040530
Proceeds from issuing equity————40530
Share repurchases—8————
Net cash from financing activities3577,2411,6788242,9011,550
Net change in cash523,129(3,230)———
  • † Share count changed about 1/96 in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Compare with peers

SIC 8011 and related industry codes, similar size; rows marked “added: same SIC” fill a short list. Each row is the latest quarter reported.

How peers are chosen
  • SIC 8011 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Fewer than three companies fall in that range, so the list adds same-SIC (8011) companies nearest in public float, each marked “added: same SIC”.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
  • A cell reading “year only” links to a 10-K that gives only the full year: without all three earlier quarters there is no fourth quarter to work out, and the year total is never shown as a quarter.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
HealthLynked13not reported(350)*3.0M0.0 quarters 10-QJun 30, 2026
Cardiff Lexingtonadded: same SIC2182,160(652)*15.6M0.3 quarters 10-QJun 30, 2026
SBC Medical Group Holdingsadded: same SIC184,31149,18822,509*102.8M— 10-QJun 30, 2026
Airsculpt Technologiesadded: same SIC18,82442,900(1,238)*72.1M15.2 quarters 10-QJun 30, 2026
Starling Oncologyadded: same SIC41,094161,28211,940*101.9M— 10-QJun 30, 2026
LifeMDadded: same SIC25,14247,281(6,926)*48.2M3.6 quarters 10-QJun 30, 2026
Teladoc Healthadded: same SIC849,909605,102106,458*182.3M— 10-QSep 30, 2026
Hims & Hers Healthadded: same SIC609,811753,214(35,939)*not reported— 10-QJun 30, 2026
Aunaadded: same SIC235,745year onlyyear onlynot reported— 20-F/ADec 31, 2024

Not investment advice. Not affiliated with the U.S. SEC.